In consequence, Wnt5a might be a suitable clinical target, at least in a subset of GC cases, fostering interest for studies addressing the molecular roles of Wnt5a in GC, which remain to be fully understood, as discussed below. This evidence concerns the gene WNT5A and gastric cancer.